{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:38:25Z","timestamp":1771472305548,"version":"3.50.1"},"reference-count":80,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>For many years in the field of onco-hematology much attention has been given to mutations in protein-coding genes or to genetic alterations, including large chromosomal losses or rearrangements. Despite this, biological and clinical needs in this sector remain unmet. Therefore, it is not surprising that recent studies have shifted from coded to non-coded matter. The discovery of non-coding RNAs (ncRNAs) has influenced several aspects related to the treatment of cancer. In particular, in chronic lymphocytic leukemia (CLL) the knowledge of ncRNAs and their contextualization have led to the identification of new biomarkers used to follow the course of the disease, to the anticipation of mechanisms that support resistance and relapse, and to the selection of novel targeted treatment regimens. In this review, we will summarize the main ncRNAs discovered in CLL and the molecular mechanisms by which they are affected and how they influence the development and the progression of the disease.<\/jats:p>","DOI":"10.3390\/ph14020168","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T22:04:15Z","timestamp":1613945055000},"page":"168","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-Coding RNAs: The \u201cDark Side Matter\u201d of the CLL Universe"],"prefix":"10.3390","volume":"14","author":[{"given":"Marcello Francesco","family":"Lingua","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, University of Turin, 10126 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-6800","authenticated-orcid":false,"given":"Giovanna","family":"Carr\u00e0","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Maffeo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-2903","authenticated-orcid":false,"given":"Alessandro","family":"Morotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer Statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.semcancer.2010.09.003","article-title":"Molecular Basis of CLL","volume":"20","author":"Pekarsky","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Arruga, F., Gyau, B.B., Iannello, A., Vitale, N., Vaisitti, T., and Deaglio, S. (2020). Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051825"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/asheducation-2017.1.329","article-title":"The Mutational Landscape of Chronic Lymphocytic Leukemia and Its Impact on Prognosis and Treatment","volume":"2017","author":"Gaidano","year":"2017","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/164_2017_12","article-title":"Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia","volume":"249","author":"Arruga","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s00277-018-3503-6","article-title":"Prognostic and Therapeutic Stratification in CLL: Focus on 17p Deletion and P53 Mutation","volume":"97","author":"Buccheri","year":"2018","journal-title":"Ann. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.seminoncol.2016.02.012","article-title":"Richter Syndrome: Pathogenesis and Management","volume":"43","author":"Rossi","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41375-019-0571-0","article-title":"Bidirectional Linkage between the B-Cell Receptor and NOTCH1 in Chronic Lymphocytic Leukemia and in Richter\u2019s Syndrome: Therapeutic Implications","volume":"34","author":"Arruga","year":"2020","journal-title":"Leukemia"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Fabris, L., Juracek, J., and Calin, G. (2020). Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186720"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminoncol.2016.02.015","article-title":"MicroRNAs in Chronic Lymphocytic Leukemia: MiRacle or MiRage for Prognosis and Targeted Therapies?","volume":"43","author":"Calin","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1158\/0008-5472.CAN-16-1248","article-title":"Finally, An Apoptosis-Targeting Therapeutic for Cancer","volume":"76","author":"Croce","year":"2016","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pepe, F., and Balatti, V. (2020). Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020593"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jcp.25799","article-title":"State of the Art in MicroRNA as Diagnostic and Therapeutic Biomarkers in Chronic Lymphocytic Leukemia","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-020-01175-9","article-title":"Role of Non-Coding RNA Networks in Leukemia Progression, Metastasis and Drug Resistance","volume":"19","author":"Bhat","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent Deletions and Down-Regulation of Micro- RNA Genes MiR15 and MiR16 at 13q14 in Chronic Lymphocytic Leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/cdd.2017.159","article-title":"BCL2 and MiR-15\/16: From Gene Discovery to Treatment","volume":"25","author":"Pekarsky","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"MiR-15 and MiR-16 Induce Apoptosis by Targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2141.2007.06600.x","article-title":"The 13q and 11q B-Cell Chronic Lymphocytic Leukaemia-Associated Regions Derive from a Common Ancestral Region in the Zebrafish","volume":"137","author":"Auer","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-4598-9-123","article-title":"MicroRNAs Involvement in Fludarabine Refractory Chronic Lymphocytic Leukemia","volume":"9","author":"Ferracin","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","article-title":"The MiR-34 Family in Cancer and Apoptosis","volume":"17","author":"Hermeking","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1038\/onc.2017.95","article-title":"Myc Enhances B-Cell Receptor Signaling in Precancerous B Cells and Confers Resistance to Btk Inhibition","volume":"36","author":"Moyo","year":"2017","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The MiR-17\/92 Cluster: A Comprehensive Update on Its Genomics, Genetics, Functions and Increasingly Important and Numerous Roles in Health and Disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell Death Differ."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","article-title":"Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by MiR-29 and MiR-181","volume":"66","author":"Pekarsky","year":"2006","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1073\/pnas.1200003109","article-title":"Tcl1 Protein Functions as an Inhibitor of de Novo DNA Methylation in B-Cell Chronic Lymphocytic Leukemia (CLL)","volume":"109","author":"Palamarchuk","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sharma, S., Pavlasova, G.M., Seda, V., Cerna, K.A., Vojackova, E., Filip, D., Ondrisova, L., Sandova, V., Kostalova, L., and Zeni, P.F. (2020). MiR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: An Axis Affected by BCR Inhibitors. Blood.","DOI":"10.1182\/blood.2020005627"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/cgt.2016.34","article-title":"Circulating MicroRNA-192 as a Diagnostic Biomarker in Human Chronic Lymphocytic Leukemia","volume":"23","author":"Fathullahzadeh","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","article-title":"MicroRNA-155 Influences B-Cell Receptor Signaling and Associates with Aggressive Disease in Chronic Lymphocytic Leukemia","volume":"124","author":"Cui","year":"2014","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35508","DOI":"10.18632\/oncotarget.16348","article-title":"Therapeutic Inhibition of USP7-PTEN Network in Chronic Lymphocytic Leukemia: A Strategy to Overcome TP53 Mutated\/Deleted Clones","volume":"8","author":"Panuzzo","year":"2017","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2010-01-263889","article-title":"MicroRNA Fingerprinting of CLL Patients with Chromosome 17p Deletion Identify a MiR-21 Score That Stratifies Early Survival","volume":"116","author":"Rossi","year":"2010","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trecan.2016.02.005","article-title":"Novel Mechanisms of Regulation of MiRNAs in CLL","volume":"2","author":"Balatti","year":"2016","journal-title":"Trends Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Li, S., Moffett, H.F., Lu, J., Werner, L., Zhang, H., Ritz, J., Neuberg, D., Wucherpfennig, K.W., Brown, J.R., and Novina, C.D. (2011). MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016956"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1073\/pnas.1019557108","article-title":"MicroRNA as Biomarkers and Regulators in B-Cell Chronic Lymphocytic Leukemia","volume":"108","author":"Moussay","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","article-title":"Prognostic Value of MiR-155 in Individuals with Monoclonal B-Cell Lymphocytosis and Patients with B Chronic Lymphocytic Leukemia","volume":"122","author":"Ferrajoli","year":"2013","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10408363.2018.1499707","article-title":"Exosome-Carried MicroRNA-Based Signature as a Cellular Trigger for the Evolution of Chronic Lymphocytic Leukemia into Richter Syndrome","volume":"55","author":"Jurj","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1182\/blood-2014-12-618470","article-title":"Characterization of CLL Exosomes Reveals a Distinct MicroRNA Signature and Enhanced Secretion by Activation of BCR Signaling","volume":"125","author":"Yeh","year":"2015","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-Cell Lymphomas: How a Complex Biology Gets More Complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer Nanomedicine: Progress, Challenges and Opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2008.377","article-title":"MiR-34a, MiR-29c and MiR-17-5p Are Downregulated in CLL Patients with TP53 Abnormalities","volume":"23","author":"Mraz","year":"2009","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2008-08-172254","article-title":"MiR-34a as Part of the Resistance Network in Chronic Lymphocytic Leukemia","volume":"113","author":"Zenz","year":"2009","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"MiR-34 - a MicroRNA Replacement Therapy Is Headed to the Clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.it.2020.08.006","article-title":"MiRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma","volume":"41","author":"Fuertes","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 Study of MRX34, a Liposomal MiR-34a Mimic, in Patients with Advanced Solid Tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgz183","article-title":"MiR-155 as a Novel Clinical Target for Hematological Malignancies","volume":"41","author":"Witten","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41576-018-0017-y","article-title":"Towards a Complete Map of the Human Long Non-Coding RNA Transcriptome","volume":"19","author":"Lagarde","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liu, Y., Sun, P., Zhao, Y., and Liu, B. (2020). The Role of Long Non-Coding RNAs and Downstream Signaling Pathways in Leukemia Progression. Hematol. Oncol.","DOI":"10.1002\/hon.2776"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e3065","DOI":"10.1002\/jgm.3065","article-title":"Long Non-Coding RNAs in Cancer: Another Layer of Complexity","volume":"21","author":"Oliveira","year":"2019","journal-title":"J. Gene Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/gcc.20885","article-title":"13q14 Deletion Size and Number of Deleted Cells Both Influence Prognosis in Chronic Lymphocytic Leukemia","volume":"50","author":"Rossi","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Garding, A., Bhattacharya, N., Claus, R., Ruppel, M., Tschuch, C., Filarsky, K., Idler, I., Zucknick, M., Caudron-Herger, M., and Oakes, C. (2013). Epigenetic Upregulation of LncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-KB. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003373"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"54174","DOI":"10.18632\/oncotarget.11099","article-title":"Upregulation of Long Noncoding RNA MIAT in Aggressive Form of Chronic Lymphocytic Leukemias","volume":"7","author":"Sattari","year":"2016","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/leu.2015.119","article-title":"P53-Dependent Non-Coding RNA Networks in Chronic Lymphocytic Leukemia","volume":"29","author":"Blume","year":"2015","journal-title":"Leukemia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm.4135","article-title":"P53 Induces Formation of NEAT1 LncRNA-Containing Paraspeckles That Modulate Replication Stress Response and Chemosensitivity","volume":"22","author":"Adriaens","year":"2016","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/cr.2014.165","article-title":"The P53-Induced LincRNA-P21 Derails Somatic Cell Reprogramming by Sustaining H3K9me3 and CpG Methylation at Pluripotency Gene Promoters","volume":"25","author":"Bao","year":"2015","journal-title":"Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12032-017-0959-5","article-title":"LincRNa-P21: Function and Mechanism in Cancer","volume":"34","author":"Chen","year":"2017","journal-title":"Med. Oncol. Northwood Lond. Engl."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"82400","DOI":"10.18632\/oncotarget.12252","article-title":"Epigenetic Silencing of Tumor Suppressor Long Non-Coding RNA BM742401 in Chronic Lymphocytic Leukemia","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1038\/bcj.2016.77","article-title":"LncRNA Profiling in Early-Stage Chronic Lymphocytic Leukemia Identifies Transcriptional Fingerprints with Relevance in Clinical Outcome","volume":"6","author":"Ronchetti","year":"2016","journal-title":"Blood Cancer J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic Targeting of Long Non-Coding RNAs in Cancer","volume":"24","author":"Arun","year":"2018","journal-title":"Trends Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1158\/0008-5472.CAN-20-1764","article-title":"Design and Functional Validation of a Mutant Variant of the LncRNA HOTAIR to Counteract Snail Function in Epithelial-to-Mesenchymal Transition","volume":"81","author":"Battistelli","year":"2021","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"49143","DOI":"10.18632\/oncotarget.9237","article-title":"Therapeutic Strategy with Artificially-Designed i-LncRNA Targeting Multiple Oncogenic MicroRNAs Exhibits Effective Antitumor Activity in Diffuse Large B-Cell Lymphoma","volume":"7","author":"Su","year":"2016","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fmolb.2020.00109","article-title":"Circular RNAs in Blood Malignancies","volume":"7","author":"Rossi","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The Biogenesis, Biology and Characterization of Circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13045-019-0734-5","article-title":"Role of MicroRNAs, CircRNAs and Long Noncoding RNAs in Acute Myeloid Leukemia","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zeni, P.F., and Mraz, M. (2020). LncRNAs in Adaptive Immunity: Role in Physiological and Pathological Conditions. RNA Biol., 1\u201314.","DOI":"10.1080\/15476286.2020.1838783"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bjh.13482","article-title":"A Rare but Recurrent t(8;13)(Q24;Q14) Translocation in B-Cell Chronic Lymphocytic Leukaemia Causing MYC up-Regulation and Concomitant Loss of PVT1, MiR-15\/16 and DLEU7","volume":"172","author":"Macchia","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-020-01187-5","article-title":"Linear and Circular PVT1 in Hematological Malignancies and Immune Response: Two Faces of the Same Coin","volume":"19","author":"Ghetti","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2018.06.045","article-title":"Circular RNA Circ-CBFB Promotes Proliferation and Inhibits Apoptosis in Chronic Lymphocytic Leukemia through Regulating MiR-607\/FZD3\/Wnt\/\u03b2-Catenin Pathway","volume":"503","author":"Xia","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41375-019-0594-6","article-title":"Circ-RPL15: A Plasma Circular RNA as Novel Oncogenic Driver to Promote Progression of Chronic Lymphocytic Leukemia","volume":"34","author":"Wu","year":"2020","journal-title":"Leukemia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.18632\/aging.101997","article-title":"Downregulation of Circ_0132266 in Chronic Lymphocytic Leukemia Promoted Cell Viability through MiR-337-3p\/PML Axis","volume":"11","author":"Wu","year":"2019","journal-title":"Aging"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Li, S., Xu, Z., and Sheng, J. (2018). TRNA-Derived Small RNA: A Novel Regulatory Small Non-Coding RNA. Genes, 9.","DOI":"10.3390\/genes9050246"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jbior.2018.12.002","article-title":"Noncoding RNA Genes in Cancer Pathogenesis","volume":"71","author":"Pekarsky","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1073\/pnas.1604266113","article-title":"Dysregulation of a Family of Short Noncoding RNAs, TsRNAs, in Human Cancer","volume":"113","author":"Pekarsky","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1073\/pnas.1500010112","article-title":"TCL1 Targeting MiR-3676 Is Codeleted with Tumor Protein P53 in Chronic Lymphocytic Leukemia","volume":"112","author":"Balatti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-019-1052-9","article-title":"The Emerging Role of the PiRNA\/Piwi Complex in Cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1073\/pnas.1706908114","article-title":"TsRNA Signatures in Cancer","volume":"114","author":"Balatti","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2010-08-304683","article-title":"Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy Is Highly Effective Treatment for Relapsed Patients with CLL","volume":"117","author":"Badoux","year":"2011","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.clml.2020.08.029","article-title":"SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia","volume":"20","author":"Condoluci","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/1078-0432.CCR-12-1922","article-title":"In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors","volume":"19","author":"Fonte","year":"2013","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10731","DOI":"10.1073\/pnas.1708264114","article-title":"MicroRNA Dysregulation to Identify Therapeutic Target Combinations for Chronic Lymphocytic Leukemia","volume":"114","author":"Rassenti","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-17-4004","article-title":"Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses","volume":"78","author":"Vaisitti","year":"2018","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood-2018-04-845115","article-title":"MiR-125a and MiR-34a Expression Predicts Richter Syndrome in Chronic Lymphocytic Leukemia Patients","volume":"132","author":"Balatti","year":"2018","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3324\/haematol.2018.203828","article-title":"The Involvement of MicroRNA in the Pathogenesis of Richter Syndrome","volume":"104","author":"Bayraktar","year":"2019","journal-title":"Haematologica"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/2\/168\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:27:19Z","timestamp":1760160439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/14\/2\/168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,21]]},"references-count":80,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ph14020168"],"URL":"https:\/\/doi.org\/10.3390\/ph14020168","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,21]]}}}